| Financial Year |
March 31 2023 |
| Monetary Funds |
618,811,835.58 |
| Held-for-trading Financial Assets |
344,777,290.88 |
| Notes Receivable |
50,185,472.60 |
| Accounts Receivable |
1,429,166,986.83 |
| Advances to Suppliers |
28,418,822.68 |
| Other Receivables |
38,490,285.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
442,054,004.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
574,466,860.53 |
| Total Current Assets |
3,625,625,296.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
68,907,173.11 |
| Investment Properties |
6,475,616.51 |
| Fixed Assetes |
378,406,450.73 |
| Under-construction Projects |
418,791,747.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
125,325,858.95 |
| R&D expenses |
-- |
| Goodwill |
1,027,307,298.64 |
| Long-Term Deferred and Prepaid Expenses |
2,660,047.35 |
| Deferred Income Tax Assets |
39,503,285.65 |
| Other Non-Current Assets |
31,148,729.00 |
| Sub-Total of Non-Current Assets |
2,367,083,172.54 |
| Total Assets |
5,992,708,468.59 |
| Short-Term Loans |
42,030,698.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
313,384,632.73 |
| Accounts Payable |
826,675,486.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
44,399,412.83 |
| Taxes Payable |
45,400,800.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
147,742,226.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,517,568.57 |
| Other Current Liabilities |
33,225,357.19 |
| Sub-Total of Current Liabilities |
1,528,791,969.64 |
| Long-term Loans |
299,353,194.62 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
35,590,445.72 |
| Deferred Income Tax Liabilities |
48,083,601.36 |
| Other Non-Current Liabilities |
55,111,337.77 |
| Sub-Total of Non-Current Liabilities |
458,284,863.80 |
| Total Liabilities |
1,987,076,833.44 |
| Paid-In Capital(Or Share Stock) |
429,054,325.00 |
| Capital Surplus |
1,784,088,327.00 |
| Surplus Reserve |
202,579,763.67 |
| LESS:Treasury Stock |
162,716,447.02 |
| Undistributed Profits |
1,584,229,924.70 |
| Minority Stockholder's Interest |
21,453,876.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,984,177,758.55 |
| Owner's Equity（Stockholder's Equity） |
4,005,631,635.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,992,708,468.59 |
